Accueil>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>Glaucine

Glaucine (Synonyms: Boldine Dimethyl Ether, (+)-Glaucine, NSC 34396, 1,2,9,10-Tetramethoxyaporphine)

Catalog No.GC41486

La Glaucine (O,O-Diméthylisoboldine) est un alcaloÏde isolé du Glaucium flavum Crantz aux propriétés antitussives, bronchodilatatrices et anti-inflammatoires.

Products are for research use only. Not for human use. We do not sell to patients.

Glaucine Chemical Structure

Cas No.: 475-81-0

Taille Prix Stock Qté
1mg
43,00 $US
En stock
5mg
161,00 $US
En stock
10mg
237,00 $US
En stock
50mg
494,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glaucine is an alkaloid originally isolated from G. flavum that demonstrates antitussive properties. It is structurally related to papaverine , a non-selective phosphodiesterase (PDE) inhibitor. Glaucine selectively inhibits PDE4 (Kis = 3.4 µM in human bronchus and polymorphonuclear leukocytes). It has been shown to have bronchodilation and anti-inflammatory effects, inhibiting the spontaneous and histamine-induced tone in human isolated bronchus and augmenting cyclic AMP accumulation. Glaucine also binds to the benzothiazepine site on L-type Ca2+-channels in smooth muscle, blocking calcium ion signaling. This compound has been detected as a recreational drug capable of eliciting dissociative effects.

Avis

Review for Glaucine

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glaucine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.